EWTX
NASDAQ
$38.81
Edgewise Therapeutics Inc (EWTX)
Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The company is headquartered in Boulder, Colorado.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $49.92 (+28.63%)
Market Cap
$4.39B
FCF 5Y CAGR
+52.26%
Free Cash Flow Yield
-3.40%
Beta (5Y)
1.37
Price Chart
Valuation
Market Cap$4.39B
P/B8.67
Profitability
EBITDA-$197M
EPS-$1.66
Financial Health
Free Cash Flow Yield-3.40%
Growth & Risk
FCF 5Y CAGR+52.26%
Beta (5Y)1.37
Sharpe Ratio1.68